Advancement in perioperative management of pituitary adenomas-Current concepts and best practices.
J Neuroendocrinol
; : e13427, 2024 Jul 04.
Article
in En
| MEDLINE
| ID: mdl-38964869
ABSTRACT
Pituitary adenomas are very common representing 18.1% of all brain tumors and are the second most common brain pathology. Transsphenoidal surgery is the mainstay of treatment for all pituitary adenomas except for prolactinomas which are primarily treated medically with dopamine agonists. A thorough endocrine evaluation of pituitary adenoma preoperatively is crucial to identify hormonal compromise caused by the large sellar mass, identifying prolactin-producing tumors and comorbidities associated with Cushing and acromegaly to improve patient care and outcome. Transsphenoidal surgery is relatively safe in the hands of experienced surgeons, but still carries a substantial risk of causing hypopituitarism that required close follow-up in the immediate postoperative period to decrease mortality. A multidisciplinary team approach with endocrinologists, ophthalmologists, and neurosurgeons is the cornerstone in the perioperative management of pituitary adenomas.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Neuroendocrinol
Journal subject:
ENDOCRINOLOGIA
/
NEUROLOGIA
Year:
2024
Document type:
Article
Affiliation country:
United States